H.C. Wainwright Starts Cell Therapeutics (CTIC) at Buy

November 4, 2013 7:34 AM EST Send to a Friend
H.C. Wainwright initiates coverage on Cell Therapeutics (NASDAQ: CTIC) with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login